IFRX
InflaRx NV
NASDAQ · Healthcare · Biotechnology · DE
$2.09
+1.46%Institutional positioning
13F filings over the trailing two quarters
New 36Increased 20Reduced 19Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 22,933,910 | Aug 14, 2026 |
| TCG Crossover Management, LLC | New Position | 14,500,000 | Aug 14, 2026 |
| FMR LLC | New Position | 8,163,341 | Aug 13, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Unchanged | 7,933,910 | May 15, 2026 |
| Commodore Capital LP | New Position | 7,300,000 | Aug 14, 2026 |
| Spruce Street Capital LP | New Position | 5,352,198 | Aug 13, 2026 |
| 683 Capital Management, LLC | Increased | 5,065,000 | Aug 14, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | New Position | 3,325,000 | Aug 14, 2026 |
| 683 CAPITAL MANAGEMENT, LLC | Unchanged | 3,315,000 | May 15, 2026 |
| STEMPOINT CAPITAL LP | New Position | 3,228,255 | Aug 14, 2026 |
| GREAT POINT PARTNERS LLC | New Position | 3,046,557 | Aug 14, 2026 |
| ADAR1 Capital Management, LLC | Increased | 3,000,000 | Aug 14, 2026 |
| Kalehua Capital Management LLC | New Position | 2,897,769 | Aug 19, 2026 |
| AMERIPRISE FINANCIAL INC | New Position | 2,572,799 | Aug 14, 2026 |
| Woodline Partners LP | New Position | 2,105,486 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings